ALCHEMIST: Bringing genomic discovery and targeted therapies to early-stage lung cancer.The identification of druggable molecular alterations represents one of the greatest advances in cancer treatment.  ALCHEMIST (Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trial) is a National Cancer Institute-sponsored initiative to address these questions in earlier-stage disease.
ALCHEMIST
ALCHEMIST: Bringing genomic discovery and targeted therapies to early-stage lung cancer.The identification of druggable molecular alterations represents one of the greatest advances in cancer treatment.  ALCHEMIST (Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trial) is a National Cancer Institute-sponsored initiative to address these questions in earlier-stage disease.
ALCHEMIST